Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

ICN PHARMACEUTICALS INC — Atrium Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / ICN PHARMACEUTICALS INC

ICN PHARMACEUTICALS INC

10% owner at Atrium Therapeutics, Inc. · on record since Aug 22, 2003

Insider trading activity of ICN PHARMACEUTICALS INC

Transactions on record: 1; since Aug 22, 2003

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Aug 22, 2003

Figures computed from official regulatory filings — methodology.

Companies where ICN PHARMACEUTICALS INC has traded

Atrium Therapeutics, Inc.1 tx · Aug 22, 2003

Track record of ICN PHARMACEUTICALS INC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of ICN PHARMACEUTICALS INC

Co-insiders of ICN PHARMACEUTICALS INC

Alexandria Venture Investments, LLCAtrium Therapeutics, Inc.
Baroldi JosephAtrium Therapeutics, Inc.
BOESS CARSTENAtrium Therapeutics, Inc.
BORON GREGORY FAtrium Therapeutics, Inc.
Boyce SarahAtrium Therapeutics, Inc.
Brady Todd CAtrium Therapeutics, Inc.
Calderaro Charles IIIAtrium Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Chen BihuaAtrium Therapeutics, Inc.

COMER WILLIAM M JRAtrium Therapeutics, Inc.

Cormorant Asset Management, LPAtrium Therapeutics, Inc.

Cormorant Global Healthcare Master Fund, LPAtrium Therapeutics, Inc.

Cormorant Private Healthcare Fund II, LPAtrium Therapeutics, Inc.

COSTA SANTO JAtrium Therapeutics, Inc.

DIMITRIADIS ANDRE CAtrium Therapeutics, Inc.

Edwards MartinAtrium Therapeutics, Inc.

Flanagan W. MichaelAtrium Therapeutics, Inc.

Gallagher Kathleen P.Atrium Therapeutics, Inc.

Henig NoreenAtrium Therapeutics, Inc.

Hoyos Rocio MartinAtrium Therapeutics, Inc.

Hughes Steven GeorgeAtrium Therapeutics, Inc.

Kaye Edward M. MDAtrium Therapeutics, Inc.

Kenney StephanieAtrium Therapeutics, Inc.

Kim Jae B.Atrium Therapeutics, Inc.

Kim Jean JinsunAtrium Therapeutics, Inc.

LAMON KIM DAVIDAtrium Therapeutics, Inc.

LEVIN ARTHUR AAtrium Therapeutics, Inc.

LILLY ELI & COAtrium Therapeutics, Inc.

MacLean Michael FAtrium Therapeutics, Inc.

Martin Michael B.Atrium Therapeutics, Inc.

McCarthy TeresaAtrium Therapeutics, Inc.

MEL DEUTSCHAtrium Therapeutics, Inc.

Moriarty John BAtrium Therapeutics, Inc.

Mosbrooker EricAtrium Therapeutics, Inc.

PARACKA DANIELAtrium Therapeutics, Inc.

PIECZYNSKI JAMESAtrium Therapeutics, Inc.

RTW INVESTMENTS, LPAtrium Therapeutics, Inc.

Skerjanec SimonaAtrium Therapeutics, Inc.

SMITH ROBERTSAtrium Therapeutics, Inc.

Thompson TamarAtrium Therapeutics, Inc.

WILSON TROY EDWARDAtrium Therapeutics, Inc.

Winslow Brendan R.Atrium Therapeutics, Inc.

WONG RODERICKAtrium Therapeutics, Inc.

Younis HusamAtrium Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Atrium Therapeutics, Inc.	Aug 22, 2003	Other	20,729,547	6.25 USD	—	SEC